ilex scientific ltd Company Information
Company Number
09656071
Next Accounts
Mar 2026
Shareholders
clive reginald hayler
heather jayne hayler
Group Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
9 vinnetrow business park, vinnetrow road, chichester, west sussex, PO20 1QH
Website
ilexscientific.comilex scientific ltd Estimated Valuation
Pomanda estimates the enterprise value of ILEX SCIENTIFIC LTD at £9.7k based on a Turnover of £24.9k and 0.39x industry multiple (adjusted for size and gross margin).
ilex scientific ltd Estimated Valuation
Pomanda estimates the enterprise value of ILEX SCIENTIFIC LTD at £0 based on an EBITDA of £-4.7k and a 2.77x industry multiple (adjusted for size and gross margin).
ilex scientific ltd Estimated Valuation
Pomanda estimates the enterprise value of ILEX SCIENTIFIC LTD at £3.8k based on Net Assets of £1.6k and 2.37x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ilex Scientific Ltd Overview
Ilex Scientific Ltd is a live company located in chichester, PO20 1QH with a Companies House number of 09656071. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in June 2015, it's largest shareholder is clive reginald hayler with a 50% stake. Ilex Scientific Ltd is a established, micro sized company, Pomanda has estimated its turnover at £24.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ilex Scientific Ltd Health Check
Pomanda's financial health check has awarded Ilex Scientific Ltd a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
8 Weak
Size
annual sales of £24.9k, make it smaller than the average company (£4.3m)
- Ilex Scientific Ltd
£4.3m - Industry AVG
Growth
3 year (CAGR) sales growth of -26%, show it is growing at a slower rate (9.2%)
- Ilex Scientific Ltd
9.2% - Industry AVG
Production
with a gross margin of 17%, this company has a higher cost of product (37.6%)
- Ilex Scientific Ltd
37.6% - Industry AVG
Profitability
an operating margin of -19.1% make it less profitable than the average company (5.6%)
- Ilex Scientific Ltd
5.6% - Industry AVG
Employees
with 1 employees, this is below the industry average (25)
- Ilex Scientific Ltd
25 - Industry AVG
Pay Structure
on an average salary of £51.3k, the company has an equivalent pay structure (£51.3k)
- Ilex Scientific Ltd
£51.3k - Industry AVG
Efficiency
resulting in sales per employee of £24.9k, this is less efficient (£158.5k)
- Ilex Scientific Ltd
£158.5k - Industry AVG
Debtor Days
it gets paid by customers after 86 days, this is later than average (38 days)
- Ilex Scientific Ltd
38 days - Industry AVG
Creditor Days
its suppliers are paid after 101 days, this is slower than average (31 days)
- Ilex Scientific Ltd
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Ilex Scientific Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Ilex Scientific Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 79.1%, this is a higher level of debt than the average (59.8%)
79.1% - Ilex Scientific Ltd
59.8% - Industry AVG
ILEX SCIENTIFIC LTD financials
Ilex Scientific Ltd's latest turnover from June 2024 is estimated at £24.9 thousand and the company has net assets of £1.6 thousand. According to their latest financial statements, we estimate that Ilex Scientific Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||
Other Income Or Grants | |||||||||
Cost Of Sales | |||||||||
Gross Profit | |||||||||
Admin Expenses | |||||||||
Operating Profit | |||||||||
Interest Payable | |||||||||
Interest Receivable | |||||||||
Pre-Tax Profit | |||||||||
Tax | |||||||||
Profit After Tax | |||||||||
Dividends Paid | |||||||||
Retained Profit | |||||||||
Employee Costs | |||||||||
Number Of Employees | 2 | 2 | 2 | 2 | |||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 1,801 | 2,402 | 2,552 | 2,524 | 2,666 | 3,554 | 2,151 | 553 | 737 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 1,801 | 2,402 | 2,552 | 2,524 | 2,666 | 3,554 | 2,151 | 553 | 737 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 5,923 | 9,248 | 11,703 | 13,085 | 59,864 | 120,520 | 33,821 | 17,868 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,622 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 5,923 | 9,248 | 11,703 | 13,085 | 59,864 | 120,520 | 33,821 | 17,868 | 6,622 |
total assets | 7,724 | 11,650 | 14,255 | 15,609 | 62,530 | 124,074 | 35,972 | 18,421 | 7,359 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 5,749 | 4,632 | 4,999 | 543 | 45,364 | 107,746 | 21,730 | 17,143 | 6,895 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 5,749 | 4,632 | 4,999 | 543 | 45,364 | 107,746 | 21,730 | 17,143 | 6,895 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 360 | 660 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 360 | 660 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 6,109 | 5,292 | 4,999 | 543 | 45,364 | 107,746 | 21,730 | 17,143 | 6,895 |
net assets | 1,615 | 6,358 | 9,256 | 15,066 | 17,166 | 16,328 | 14,242 | 1,278 | 464 |
total shareholders funds | 1,615 | 6,358 | 9,256 | 15,066 | 17,166 | 16,328 | 14,242 | 1,278 | 464 |
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||
Operating Profit | |||||||||
Depreciation | 246 | ||||||||
Amortisation | 0 | ||||||||
Tax | |||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -3,325 | -2,455 | -1,382 | -46,779 | -60,656 | 86,699 | 15,953 | 17,868 | 0 |
Creditors | 1,117 | -367 | 4,456 | -44,821 | -62,382 | 86,016 | 4,587 | 10,248 | 6,895 |
Accruals and Deferred Income | -300 | 660 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||
Investing Activities | |||||||||
capital expenditure | |||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||
Financing Activities | |||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||
interest | |||||||||
cash flow from financing | |||||||||
cash and cash equivalents | |||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,622 | 6,622 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,622 | 6,622 |
ilex scientific ltd Credit Report and Business Information
Ilex Scientific Ltd Competitor Analysis
Perform a competitor analysis for ilex scientific ltd by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in PO20 area or any other competitors across 12 key performance metrics.
ilex scientific ltd Ownership
ILEX SCIENTIFIC LTD group structure
Ilex Scientific Ltd has no subsidiary companies.
Ultimate parent company
ILEX SCIENTIFIC LTD
09656071
ilex scientific ltd directors
Ilex Scientific Ltd currently has 2 directors. The longest serving directors include Mr Clive Hayler (Jun 2015) and Ms Heather Hayler (Jun 2015).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Clive Hayler | United Kingdom | 69 years | Jun 2015 | - | Director |
Ms Heather Hayler | England | 63 years | Jun 2015 | - | Director |
P&L
June 2024turnover
24.9k
-19%
operating profit
-4.7k
0%
gross margin
17%
-3.13%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
1.6k
-0.75%
total assets
7.7k
-0.34%
cash
0
0%
net assets
Total assets minus all liabilities
ilex scientific ltd company details
company number
09656071
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
June 2015
age
10
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
June 2024
previous names
N/A
accountant
-
auditor
-
address
9 vinnetrow business park, vinnetrow road, chichester, west sussex, PO20 1QH
Bank
-
Legal Advisor
-
ilex scientific ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ilex scientific ltd.
ilex scientific ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ILEX SCIENTIFIC LTD. This can take several minutes, an email will notify you when this has completed.
ilex scientific ltd Companies House Filings - See Documents
date | description | view/download |
---|